Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Shareholder Alert - Bleichmar Fonti & Auld LLP Files Securities Class Action Lawsuit Against McKesson Corporation

MCK

NEW YORK, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Bleichmar Fonti & Auld LLP (“BFA”) announces that it has filed a class action lawsuit on behalf of a class (the “Class”) consisting of persons and entities that acquired McKesson Corporation (“McKesson” or the “Company”) (NYSE:MCK) common stock between October 24, 2013 and January 25, 2017, inclusive (the “Class Period”). The case was filed in the Northern District of California and is captioned Evanston Police Pension Fund v. McKesson, No. 3:18-cv-06525.

McKesson delivers pharmaceutical and medical products and business services to retail pharmacies and institutional healthcare providers such as hospitals and health systems throughout North America and internationally. The majority of its income is derived from its business as a pharmaceutical wholesaler in which it purchases drugs in bulk directly from manufacturers and then sells and distributes those drugs to pharmacy networks, hospitals, and independent pharmacies. 

The Complaint asserts claims for violations of the Securities Exchange Act of 1934 against McKesson, its Chief Executive Officer (“CEO”) John H. Hammergren, and its former Chief Financial Officer (“CFO”) James Beer.

According to the Complaint, throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (i) McKesson and several of its industry peers colluded to fix the price of certain generic drugs; (ii) the collusive conduct constituted a violation of federal antitrust laws; (iii) consequently, McKesson’s revenues during the Class Period were, in part, the result of illegal conduct and were therefore unsustainable; (iv) McKesson lacked effective internal controls over financial reporting; and (v) as a result, McKesson’s public statements were materially false and misleading at all relevant times.

If you are a member of the Class, you may move the Court no later than 60 days from the date of this notice, to serve as Lead Plaintiff. For additional information, or to view a copy of the complaint, please visit https://www.bfalaw.com/

BFA is a law firm based in New York City with additional offices in Oakland, California and Toronto, Canada. The Firm focuses on securities fraud class actions and other investment-related matters. BFA currently serves as lead counsel in multiple securities class actions and has recovered hundreds of millions of dollars for investors. For more information about BFA, or for additional information about participating in this action, please visit https://www.bfalaw.com/.

Joseph A. Fonti, Esq., Wilson M. Meeks, Esq., Bleichmar Fonti & Auld, LLP

7 Times Square, 27th Floor, New York, NY 10036, (212) 789-1340, info@bfalaw.com.

logo_300dpi.jpg



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today